Ameriprise’s Doximity DOCS Stock Holding History

Ameriprise’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,600	Closed	-$731K	–	4003
2025 Q1	$731K	Buy	+12,600	New	+$796K	﹤0.01%	3342

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ameriprise's DOCS Position: Q2 2026 in Review

Ameriprise reduced its Doximity (DOCS) stake by 83% in Q2 2026, selling an estimated $11.8M and leaving 110,773 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Ameriprise first reported a position in DOCS in Q2 2021 and has held it in 21 quarters since. The position peaked at $297M in Q1 2022. 359 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

Ameriprise held 110,773 shares of Doximity worth $2.3M as of Q2 2026.
Ameriprise sold 533,506 Doximity shares in Q2 2026, an estimated $11.8M.
Doximity made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3003 holding.
Ameriprise first reported a position in Doximity in Q2 2021 and has held it in 21 quarters since.
Ameriprise's Doximity position peaked at $297M in Q1 2022.
359 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.